Gene expressions and cellular adhesion in experimental carcinogenesis of rat submandibular gland
Gene expressions and cellular adhesion in experimental carcinogenesis of rat submandibular gland
批准号:
09671937
负责人:
SUMITOMO Shinichiro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
A process of carcinogenesis in rat submandibular gland(SMG),following the 2%DMBA containing sponge pellet insertion,was studied by the use of several histochemical markers and RT-PCR。K8.12cytokeratin,epidermal growth factor,endothelin-3and S-100 protein were used for the imunohistochemical markers of salivary gland duct。Calponin was used for the imunohistochemical marker of mioepithelial cells.Proliferating cell nuclear antigen imunohistochemistry and I D13 IED1H-thymidine auto-radiograph were used to obtain proliferating potential.Basis fibroblast growth factor(BFGF)and its receptor(FGFr),and c-erbB-2were studied as oncogene products.During the carcinogenesis,proliferating cells were found in several kinds of ductal cells,though acinar compartment including myoepithelial cells showed no or minimal proliferating protential.In the histological patterns of carcinoma in rat SMG,the differentiation and/or conduction of modified myoepithelial cells may deeply influenced to form tubro-ductal structures in adenocarcinoma.There were no calponin positive modified myoepithelial cells found in squamous cell carcinoma,through in the adenomacarcinoma,they were arranged in the basal layer of the proliferating and dysplastic tubro-ductal structures.In the variation of oncogene products during carinogenesis,bFGF and FGFr were enhanced their immunohistochemical expression in the tumor nest and coexisted in the same tumor cells。These result may suggest that,bFGF may stimulate carcinogenesis by autocrin and/or paracrin pathway。Furthermore,a progression of carcinogenesis brought to increase of c-erbB-2mRNA level.RT-PCR product of c-erbB-2was absent in normal SMG and 3weeks of carnogenesis but showed harlf and all cases in6weeks and in12weeks specimens,respectively.Excessive c-erbB-2prot-oncogene product may be one of a course for SMG carcinogenesis following DMBA administration。
英文摘要
A process of carcinogenesis in rat submandibular gland (SMG), following the 2%DMBA containing sponge pellet insertion, was studied by the use of several histochemical markers and RT-PCR. K8.12 cytokeratin, epidermal growth factor, endothelin-3 and S-100 protein were used for the imunohistochemical markers of salivary gland duct. Calponin was used for the imunohistochemical marker of mioepithelial cells. Proliferating cell nuclear antigen imunohistochemistry and ィイD13ィエD1H-thymidine auto-radiograph were used to obtain proliferating potential. Basis fibroblast growth factor (bFGF) and its receptor (FGFr), and c-erbB-2 were studied as oncogene products.During the carcinogenesis, proliferating cells were found in several kinds of ductal cells, though acinar compartment including myoepithelial cells showed no or minimal proliferating protential. In the histological patterns of carcinoma in rat SMG, the differentiation and/or conduction of modified myoepithelial cells may deeply influenced to form tubro-ductal structures in adenocarcinoma. There were no calponin positive modified myoepithelial cells found in squamous cell carcinoma, through in the adenomacarcinoma, they were arranged in the basal layer of the proliferating and dysplastic tubro-ductal structures.In the variation of oncogene products during carinogenesis, bFGF and FGFr were enhanced their immunohistochemical expression in the tumor nest and coexisted in the same tumor cells. These result may suggest that, bFGF may stimulate carcinogenesis by autocrin and/or paracrin pathway. Furthermore, a progression of carcinogenesis brought to increase of c-erbB-2 mRNA level. RT-PCR product of c-erbB-2 was absent in normal SMG and 3 weeks of carnogenesis but showed harlf and all cases in 6 weeks and in 12 weeks specimens, respectively. Excessive c-erbB-2 prot-oncogene product may be one of a course for SMG carcinogenesis following DMBA administration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
岡本吉史: "ラット顎下腺におけるc-erbB2遺伝子の発現"日口科誌. 48(1). 1-9 (1999)
Yoshifumi Okamoto:“c-erbB2 基因在大鼠颌下腺中的表达”日本医学杂志 48(1) 1-9 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Okamoto, S.Sumitomo et al.: "Expression of c-erbB-2 oncoprotein during rat submandibular gland carcinogenesis"Int.J.Oral.Maxillofac.Surg.. 26(S1). 182-183 (1997)
Y.Okamoto、S.Sumitomo 等人:“大鼠颌下腺癌变过程中 c-erbB-2 癌蛋白的表达”Int.J.Oral.Maxillofac.Surg. 26(S1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
R.Bhattacharya, M.Mori et al: "Circadian Rhythm of Metallthionein Distribution in Liver, Kidney and Salivary gland of Rats"Policlinic Sez. Med.(Chronob). 105. 1-10 (1998)
R.Bhattacharya、M.Mori 等人:“大鼠肝脏、肾脏和唾液腺中金属硫蛋白分布的昼夜节律”Policlinic Sez。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Okamoto, S.Sumitomo et.al.: "Expression of c-erbB-2 oncoprotein during rat submandibular gland carcinogenesis." Int.J.Oral Maxillofac.Surg.26(S1). 182-183 (1997)
Y.Okamoto、S.Sumitomo 等人:“大鼠颌下腺癌变过程中 c-erbB-2 癌蛋白的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Sumitomo Y.Okamoto et al: "Immunohistochemical study of fibroblast growth factor-2(FGF2) and fibroflast growth factor receptor(FGR-R) in experimentalsquamous cell carcinoma of rat submandibular gland"Oral Oncology, Eur J Cancer. 35(1). 98-1040 (1999)
S.Sumitomo Y.Okamoto 等人:“大鼠颌下腺实验性鳞状细胞癌中成纤维细胞生长因子-2(FGF2)和成纤维细胞生长因子受体(FGR-R)的免疫组织化学研究”口腔肿瘤学,Eur J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Gene expression during Experimental Carcinogenesis of Rat Submandibular Gland DNA Array Study
-
批准号:14571803
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2002
-
负责人:SUMITOMO Shinichiro
-
依托单位:
Gene expressions in experimental carcinogenesis of rat submandibular gland and salivary gland tumors of human being
-
批准号:12671841
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2000
-
负责人:SUMITOMO Shinichiro
-
依托单位:
Investigation of stam cells in experimental salivary gland carcinogenesis. (Immunohistochemical evaruation for oncogene product)
-
批准号:07672064
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:SUMITOMO Shinichiro
-
依托单位:
海外基金